Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone acetate plus ADT vs ADT alone in high-risk metastatic hormone‑naïve prostate cancer
CTR20132473Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of abiraterone in prostate cancer (PCa), sponsored by Janssen Pharmaceutical. Started Jan 2015; status: completed.
02
Drugs
abiraterone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on CTR20132473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132473.